...thermocycler provides maximum performance on minim...ements, high heating and cooling rates have been a...aximum capacity of 48 x 0.2ml tubes, the Tpersonal... 96 well instruments. Alternatively, the instrumen...
Dual-bay Dyad thermal cycler chassis from Bio-Rad
Artisan™ Wash Solution (x 50) from Dako
...ophosphatase Secondary Detection System is intende...Primary Antibody reagents, which contain rat and g...gens by light microscopy in paraffin-embedded tiss...tection System may also be used with other rat or ...
Biology Products:(Date:11/22/2009)...bridge, MA November 23, 2009 Agios Pharmaceutica...ished, for the first time, that the mutated IDH1 g...cancer-causing gene, or oncogene. This breakthroug...oduces a metabolite, 2-hydroxyglutarate (2HG), whi...rogression of gliomas, the most common type of bra...
(Date:11/20/2009)...T researchers are at work on many scientific and t...ation has recently provided support that totals ne...ollowing investigators under the American Recovery...ers have been awarded grants for investigation of ...ofessor of physics, will enhance the capabilities ...
(Date:11/20/2009)... highly precise measurements of plasma lipoprotein...onance spectroscopy (NMR), researchers led by Dani...vard Medical School in Boston, MA, the Framingham ...rtium in Stockholm, Sweden and Oxford, England per...le genome among 17,296 women of European ancestry ...
Breaking Biology News(10 mins):Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2Patrick Soon Shiong World Renowned Healthcare Visionary 26amp 3B Philanthropist to Receive ABL 26apos 3Bs Leadership Award 26amp 3B Make Keynote P 59619 1Patrick Soon Shiong World Renowned Healthcare Visionary 26amp 3B Philanthropist to Receive ABL 26apos 3Bs Leadership Award 26amp 3B Make Keynote P 59619 2Patrick Soon Shiong World Renowned Healthcare Visionary 26amp 3B Philanthropist to Receive ABL 26apos 3Bs Leadership Award 26amp 3B Make Keynote P 59619 3Patrick Soon Shiong World Renowned Healthcare Visionary 26amp 3B Philanthropist to Receive ABL 26apos 3Bs Leadership Award 26amp 3B Make Keynote P 59619 4Swanson Health Products Joins Peggy Fleming in Promoting the Heart Health Benefits of Ubiquinol a CoQ10 Dietary Supplement 59616 1Swanson Health Products Joins Peggy Fleming in Promoting the Heart Health Benefits of Ubiquinol a CoQ10 Dietary Supplement 59616 2Swanson Health Products Joins Peggy Fleming in Promoting the Heart Health Benefits of Ubiquinol a CoQ10 Dietary Supplement 59616 3Cell Therapeutics Inc Annual Meeting of Shareholders Scheduled for Tuesday October 20 2009 59613 1Cell Therapeutics Inc Annual Meeting of Shareholders Scheduled for Tuesday October 20 2009 59613 2(Date:11/20/2009)... METTLER TOLEDO recently announ...e webinar, “The Role of Process Analytical T...eering” on December 1, 2009. , ...e The Role of Process Analytical Technology (PAT)... on December 1, Process Analytical Technology (PAT...
(Date:11/19/2009)..., SEATTLE, Nov. 19 Om...unaudited financial results for the third quarter ...ed September 30, 2009, Omeros reported a net loss ...o a net loss of $7.4 million, or $2.54 per share, ...nded September 30, 2009, the Company reported a ne...
(Date:11/19/2009)..., NEW YORK, Nov. 19 N...hat it has sent the following letter to its shareh...ctober 30, 2009, of China Biopharmaceuticals Holdi... company based in the People,s Republic of China. ...t in Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,s p...
(Date:11/19/2009)... , MUNSTER, Germany, November 19 /PRNewsw...have filed on November 16th, 2009 Flibanserin in t...dyskinesia in Parkinson,s,disease for orphan drug ...ncy,(EMEA). Levodopa-induced dyskinesia is a compl...inson,s and a serious burden to some of those,affe...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2